Online Database of Chemicals from Around the World

D-Luciferin
[CAS# 2591-17-5]

List of Suppliers
Discovery Fine Chemicals Ltd. UK Inquire  
+44 (1202) 874-517
pjc@discofinechem.com
Chemical manufacturer
chemBlink standard supplier since 2009
AAT Bioquest, Inc. USA Inquire  
+1 (408) 733-1055
jack@aatbio.com
Chemical manufacturer since 2005
chemBlink standard supplier since 2010
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Carbosynth China Ltd. China Inquire  
+86 (512) 6260-5585
sales@carbosynth.com
QQ chat
Chemical manufacturer since 2006
chemBlink standard supplier since 2016
Zhangshu Hongyuan Biomedical Technology Co., Ltd. China Inquire  
+86 19195036662
335864138@qq.com
QQ chat
Chemical manufacturer since 2022
chemBlink standard supplier since 2022
Hubei Innerse Biotechnology Co., Ltd. China Inquire  
+86 (027) 8818-9299
sales@innersebio.com
QQ chat
Chemical manufacturer since 2020
chemBlink standard supplier since 2025
ChemPur GmbH Germany Inquire  
+49 (721) 933-840
info@chempur.de
Chemical manufacturer
Indofine Chemical Company, Inc. USA Inquire  
+1 (888) 463-6346
info@indofinechemical.com
Chemical manufacturer since 1981
Complete supplier list of D-Luciferin
Identification
Classification Pharmaceutical intermediate >> Heterocyclic compound intermediate
Name D-Luciferin
Synonyms (S)-4,5-Dihydro-2-(6-hydroxybenzothiazol-2-yl)thiazole-4-carboxylic acid
Molecular Structure CAS # 2591-17-5, D-Luciferin, (S)-4,5-Dihydro-2-(6-hydroxybenzothiazol-2-yl)thiazole-4-carboxylic acid
Molecular Formula C11H8N2O3S2
Molecular Weight 280.32
CAS Registry Number 2591-17-5
EC Number 219-981-3
SMILES C1[C@@H](N=C(S1)C2=NC3=C(S2)C=C(C=C3)O)C(=O)O
Properties
Density 1.8±0.1 g/cm3 Calc.*
Melting point 200 - 204 ºC (Expl.)
Boiling point 587.6±60.0 ºC 760 mmHg (Calc.)*
Flash point 309.2±32.9 ºC (Calc.)*
Solubility 10 mM (DMSO) (Expl.)
Index of refraction 1.865 (Calc.)*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H315-H319-H335    Details
Precautionary Statements P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2H319
SDS Available
up Discovory and Applicatios
D-Luciferin is an heterocyclic organic compound with the molecular formula C11H8N2O3S. Structurally, it consists of a benzothiazole ring fused to a thiazoline ring, with a hydroxyl group at the 6-position of the benzothiazole and a carboxylic acid at the 4-position of the thiazoline ring. The molecule exists in the naturally occurring D-enantiomer, which is the biologically active form recognized by luciferase enzymes in bioluminescent organisms. D-Luciferin is typically a pale yellow solid, soluble in aqueous and polar organic solvents under appropriate conditions.

D-Luciferin is best known as the substrate for luciferase-catalyzed bioluminescence. In the presence of luciferase, adenosine triphosphate (ATP), and oxygen, D-Luciferin undergoes oxidation to produce light. This reaction forms the basis of bioluminescence in fireflies and other bioluminescent organisms and is widely exploited in molecular and cellular biology as a reporter system. The light emission is highly sensitive and can be quantified to monitor gene expression, cell viability, and biochemical processes in vitro and in vivo.

The compound is also used extensively in bioluminescence imaging applications. In live cells, tissues, and whole organisms, D-Luciferin enables non-invasive imaging of biological processes. Modifications of luciferin, such as creating derivatives with altered substituents, can tune emission wavelength, improve tissue penetration, or optimize signal stability for research purposes.

Synthetically, D-Luciferin can be prepared by condensation of appropriate benzothiazole derivatives with cysteine, forming the thiazoline ring and introducing the carboxylic acid group. The D-enantiomer is obtained using the corresponding enantiomer of cysteine, ensuring compatibility with luciferase. Handling requires standard precautions for heterocyclic compounds, and solutions are typically protected from light to prevent photodegradation.

Overall, D-Luciferin is a versatile and essential compound in biochemistry and molecular biology. Its benzothiazole-thiazoline core, hydroxyl group, and stereochemically defined carboxylate moiety are critical for enzymatic recognition and light emission, making it a central tool in bioluminescence assays, imaging studies, and biochemical research.

References

2020. Rapid and simple screening of the apoptotic compounds based on Hsp70 inhibition using luciferase as an intracellular reporter. Analytical and Bioanalytical Chemistry, 412(3).
DOI: 10.1007/s00216-019-02220-3

2021. Curbing gastrointestinal infections by defensin fragment modifications without harming commensal microbiota. Communications Biology, 4(1).
DOI: 10.1038/s42003-020-01582-0

2021. A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin. Drug Delivery and Translational Research, 11(3).
DOI: 10.1007/s13346-021-00920-x
Market Analysis Reports
List of Reports Available for D-Luciferin
Related Products
Lupulone beta-acid  Lurasidone  Lurasidone hydrochloride  Lurasidone Impurity 22  Lurasidone Impurity 6  Lurasidone Impurity 7  Lucidenic acid N  Lucidone  Luciferase  Luciferase (firefly luciferin)  L-Luciferin  D-Luciferin 6'-O-phosphate trisodium salt  D-Luciferin potassium salt  D-Luciferin sodium salt  Lucyoside B  Lufenuron  Luisol A  Luliconazole  Lumateperone  Lumazine